Alex Reyentovich
Overview
Explore the profile of Alex Reyentovich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Soman P, Khouri M, Lenihan D, Reyentovich A, Sperry B, Sowalsky K, et al.
Future Cardiol
. 2025 Jan;
21(2):75-81.
PMID: 39878480
Introduction: The 6-minute walk test (6MWT) is used to assess submaximal exercise capacity in clinical trials. Conducting the 6MWT can be challenging when patients cannot visit the clinic due to...
2.
Leiva O, Golob S, Reyentovich A, Alvarez-Cardona J, Bloom M, Halpern D, et al.
Clin Transplant
. 2025 Jan;
39(1):e70077.
PMID: 39777762
Introduction: Patients with congenital heart disease (CHD) are at increased risk of cancer. In patients with CHD and advanced heart failure, isolated heart transplantation (HT) can be considered. In the...
3.
Russum S, Sayin I, Shwetar J, Baughan E, Jeong J, Kim A, et al.
bioRxiv
. 2024 Dec;
PMID: 39713394
Long-term allograft survival is limited by humoral-associated chronic allograft rejection, suggesting inadequate constraint of humoral alloimmunity by contemporary immunosuppression. Heterogeneity in alloreactive B cells and the incomplete definition of which...
4.
Kadosh B, Patel S, Sidhu S, Massie A, Golob S, Goldberg R, et al.
J Heart Lung Transplant
. 2024 Nov;
44(3):378-385.
PMID: 39603482
Background: In the 2018 Organ Procurement and Transplantation Network donor heart allocation system, patients listed for re-transplantation due to cardiac allograft vasculopathy (CAV) are assigned to Status 4 unless hemodynamic...
5.
Golob S, Leiva O, Goldberg R, Kadosh B, Nazeer H, Alam A, et al.
Clin Transplant
. 2024 Nov;
38(11):e70032.
PMID: 39575512
Background: Because of advances in medical treatment of heart failure, patients are living longer than in previous eras and may approach the need for advanced therapies, including heart transplantation, at...
6.
Sidhu S, Kadosh B, Tang Y, Sweeney G, Pierre A, Whiteson J, et al.
J Cardiopulm Rehabil Prev
. 2024 Oct;
45(1):46-50.
PMID: 39475812
Purpose: Cardiac rehabilitation (CR) is beneficial in heart transplant and left ventricular assist device (LVAD) recipients, but patterns of attendance remain poorly understood. We describe CR adherence and cessation in...
7.
Gurin M, Xia Y, Tarabanis C, Goldberg R, Knotts R, Donnino R, et al.
Am Heart J Plus
. 2024 Jul;
44:100421.
PMID: 39070127
Background: Catheter ablation (CA) for ventricular tachycardia (VT) can be a useful treatment strategy, however, few studies have compared CA to medical therapy (MT) in the sarcoidosis population. Objective: To...
8.
Kumar A, Alam A, Flattery E, Dorsey M, Yongue C, Massie A, et al.
Ann Thorac Surg
. 2024 Apr;
118(3):552-563.
PMID: 38642820
Since the development of the first heart allocation system in 1988 to the most recent heart allocation system in 2018, the road to heart transplantation has continued to evolve. Policies...
9.
Kadosh B, Birs A, Flattery E, Stachel M, Hong K, Xia Y, et al.
Clin Transplant
. 2024 Mar;
38(4):e15294.
PMID: 38545881
Background: Recent studies suggest the transplantation of Hepatitis C (HCV) hearts from viremic donors is associated with comparable 1 year survival to nonviremic donors. Though HCV viremia is a known...
10.
Motter J, Jaffe I, Moazami N, Smith D, Kon Z, Piper G, et al.
Clin Transplant
. 2024 Mar;
38(3):e15269.
PMID: 38445531
Introduction: Thoracoabdominal normothermic regional perfusion (TA-NRP) following cardiac death is an emerging multivisceral organ procurement technique. Recent national studies on outcomes of presumptive TA-NRP-procured organs are limited by potential misclassification...